Company Profile
Updated: 17-SEP-09DNA Publications Inc.
Private Company, Headquarters Location
PO Box 2988, Radford, VA 24143-2988, United States
(540)763-2925, (540)763-2924 fax, http://www.dnapublications.com
Primary SIC: Book Publishing & Printing, Primary NAICS: Book Publishers
Description: Manufacturing: Publishes 5 magazines, including the monthly magazine Science Fiction Chronicle. Publications also available in microform. Accepts unsolicited manuscripts. Reaches market through direct mail, trade sales, and wholesalers
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Researchers from Columbus Children's Hospital report details of new studies and findings in the area of medical genetics.(Clinical report)
Genomics & Genetics Weekly; 12/11/2009; 690 words; ...Similar cases have been reported in four publications." "Analysis of pedigree data from the...COL2A1 gene. Molecular analysis of genomic DNA of these patients excluded this gene...Wiley-Liss, Division John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030...
Data on carcinogenesis described by A.R. Boobis et al.
Cancer Weekly; 12/1/2009; 611 words; ...information for the journal Toxicologic Pathology is: Sage Publications Inc., 2455 Teller Rd., Thousand Oaks, CA 91320, USA...Country:United States, Cancer, Carcinogenesis, DNA, Oncology, Pathology This article was prepared by Cancer...
Findings from D. Milkovic and co-authors provide new insights into environmental - toxicology.
Life Science Weekly; 12/1/2009; 605 words; ...this work is to assess DNA damage in peripheral blood...of Toxicology (Primary DNA Damage Assessed With the...be contacted at: Sage Publications Inc., 2455 Teller Rd...Zagreb, Country:Croatia, DNA Damage, DNA Research...
Lorus Therapeutics Announces Positive Result in Its Phase II Clinical Study of LOR-2040 in Acute Myeloid Leukemia (AML); -Efficacy and safety data supports advancement to a comparative trial as a strategy to support registration-.(Clinical report)
Marketwire Canada; 11/30/2009; 1929 words; ...COMTEX) -- Lorus Therapeutics Inc. (TSX:LOR) ("Lorus...peer review presentation and publication, and will be disclosed in more...reductase, which is required for DNA synthesis and cell proliferation...anticancer drugs. Lorus Therapeutics Inc. is listed on the Toronto Stock...
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants.
Business Wire; 11/25/2009; 1459 words; ...announced that Merck & Co., Inc., through an affiliate...data presentations and publications based on the work conducted...Idera Pharmaceuticals, Inc. Idera Pharmaceuticals...responses. Our pioneering DNA and RNA chemistry expertise...Idera Pharmaceuticals, Inc. that involve a number...
Recent News Articles
- Applied DNA Sciences Inc. Retains Rubenstein Public Relations.
PR Newswire - March 28, 2005
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning